Brief: Gain Therapeutics Presents Preclinical Data On Its Structurally Targeted Allosteric Regulators In GBA1 Gaucher Disease
08/02/2022 13:34
Feb 8 (Reuters) - Gain Therapeutics Inc GANX.O :
* GAIN THERAPEUTICS PRESENTS PRECLINICAL DATA ON ITS
STRUCTURALLY
TARGETED ALLOSTERIC REGULATORS IN GBA1 GAUCHER DISEASE AT THE
WORLDSYMPOSIUM 2022
Source text for Eikon: ID:nGNX848GGt
Further company coverage: GANX.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Gain Therapeutics
See all newsU.S. STOCKS ON THE MOVEX-Abbott, Columbia Financial, Jabil
U.S. STOCKS ON THE MOVEX-Abbott, Columbia Financial, Jabil,
Gain Therapeutics climbs on narrower-than-expected quarterly loss
Gain Therapeutics Inc reports results for the quarter ended June 30 - Earnings Summary
Gain Therapeutics Q2 net loss per share narrows as R&D expenses fall